Answers are grounded in this paper and cite their sources.
Piezoelectric biopolymers are promising candidates for next-generation biomedical devices, uniquely capable of converting biomechanical motion into functional electrical signals while offering inherent biocompatibility and sustainability. This review establishes a unified multiscale framework linking molecular structure, processing, architecture, and device function. We first examine the piezoelectric mechanism, specifically the direct and inverse effects arising from oriented dipoles in hierarchical structures, and then classify the principal biopolymer families. We then survey fabrication strategies that govern crystallinity, orientation, and output, as well as structural-engineering designs that reconcile high electrical output with mechanical compliance and durability. Relative to conventional ceramic and fluoropolymer piezoelectrics, biopolymers trade lower coefficients for biodegradability, modulus matching, and low immunogenicity. State-of-the-art material systems and processing techniques are summarized to showcase recent progress toward high-fidelity tissue regeneration and reliable biosensing. Applications span wearable and implantable biosensors, self-powered systems, soft-robotic therapeutics, and electroactive scaffolds for bone, dental, and neural regeneration, in which degradation becomes a design variable, with resorption tuned to healing timelines. Finally, we assess translational challenges, including modulus mismatch, suboptimal coefficients, degradation-healing misalignment, scalability, and regulatory validation. We also outline future directions in theranostic, artificial-intelligence-integrated, and carbon-neutral platforms. Piezoelectric biopolymers thus emerge as foundational components of adaptive, sustainable, and patient-centric biomedical technologies.
No takes yet. Share an insight, caveat, or question.
Akram et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: